Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Evolent Health Inc before investing.
In this article, we go over a few key elements for understanding Evolent Health Inc’s stock price such as:
- Evolent Health Inc’s current stock price and volume
- Why Evolent Health Inc’s stock price changed recently
- Upgrades and downgrades for EVH from analysts
- EVH’s stock price momentum as measured by its relative strength
About Evolent Health Inc
(EVH)
Before we jump into Evolent Health Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Evolent Health, Inc. is a health care company that delivers clinical and administrative solutions to payers and providers. The Company supports health systems and physician organizations as well as health plans to move their business models from traditional fee-for-service reimbursement to value-based care. The Company operates through two segments: Clinical Solutions and Evolent Health Services. The Clinical Solutions segment includes its specialty management and physician-oriented total cost of care solutions, along with the New Century Health, Vital Decisions, IPG, NIA, and Evolent Care Partners brands. Its Clinical Solutions segment offers two solutions, namely specialty care management services and total cost of care management. Its care management services include population health performance and delivery network alignment. The Evolent Health Services segment includes integrated value-based care platform designed to help its customers manage and administer patient health.
Want to learn more about Evolent Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Evolent Health Inc.
Evolent Health Inc’s Stock Price as of Market Close
As of November 03, 2023, 4:00 PM, CST, Evolent Health Inc’s stock price was $27.26.
Evolent Health Inc is up 13.54% from its previous closing price of $24.01.
During the last market session, Evolent Health Inc’s stock traded between $23.49 and $24.82. Currently, there are 111.28 million shares of Evolent Health Inc stock available for purchase.
Unfortunately, Evolent Health Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.
Evolent Health Inc Stock Price History
Evolent Health Inc’s
(EVH) price is currently up 11.58% so far this month.
During the month of November, Evolent Health Inc’s stock price has reached a high of $27.91 and a low of $23.49.
Over the last year, Evolent Health Inc has hit prices as high as $36.70 and as low as $21.83. Year to date, Evolent Health Inc’s stock is down 1.48%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Evolent Health Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 02, 2023, there was 1 analyst who downgraded Evolent Health Inc’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Evolent Health Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Evolent Health Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Evolent Health Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Evolent Health Inc
(EVH) by visiting AAII Stock Evaluator.
Relative Price Strength of Evolent Health Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of November 02, 2023, Evolent Health Inc has a weighted four-quarter relative price strength of -8.07%, which translates to a Momentum Score of 41 and is considered to be Average.
Want to learn more about how Evolent Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Evolent Health Inc Stock Price: Bottom Line
As of November 3, 2023, Evolent Health Inc’s stock price is $27.26, which is up 13.54% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Evolent Health Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.